Osimertinib vs Sacituzumab Govitecan

## Osimertinib vs Sacituzumab Govitecan: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Sacituzumab Govitecan**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Sacituzumab Govitecan — N/A.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Sacituzumab Govitecan — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Sacituzumab Govitecan — N/A.

**Type**: Osimertinib — Small molecule; Sacituzumab Govitecan — Antibody drug conjugate.